Development of classification and response criteria for rheumatic diseases
- PMID: 16739201
- DOI: 10.1002/art.22003
Development of classification and response criteria for rheumatic diseases
Abstract
RELEVANCE TO THE CLINICIAN: Clinicians already know that not all patients who are diagnosed with rheumatic diseases really have them. Moreover, determining which patients have improved and by how much is also difficult. Classification criteria allow clinical researchers to recruit patients with similar diseases (e.g., rheumatoid arthritis or systemic lupus erythematosus) into studies. Response criteria help to determine whether treatments really work, i.e., whether they actually produce clinically important improvement. As the science of clinical research advances, we must update our standards for considering classification and response criteria. In this editorial, members of the American College of Rheumatology (ACR) Subcommittee on Classification and Response Criteria describe the purpose of criteria sets, their development and validation, and the role of the ACR in adopting them.
Comment in
-
Revising the classification criteria for systemic sclerosis.Arthritis Rheum. 2006 Dec 15;55(6):992-3. doi: 10.1002/art.22364. Arthritis Rheum. 2006. PMID: 17139623 No abstract available.
Similar articles
-
The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement.Arthritis Rheum. 2006 Jun 15;55(3):355-63. doi: 10.1002/art.22002. Arthritis Rheum. 2006. PMID: 16739203
-
[Nosologic criteria in rheumatology].Z Rheumatol. 1996 Sep-Oct;55(5):319-30. Z Rheumatol. 1996. PMID: 9036718 Review. German.
-
The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials.Arthritis Rheum. 2006 Feb;54(2):421-32. doi: 10.1002/art.21625. Arthritis Rheum. 2006. PMID: 16453282 No abstract available.
-
The Paediatric Rheumatology International Trials Organization (PRINTO).Lupus. 2007;16(8):670-6. doi: 10.1177/0961203307079556. Lupus. 2007. PMID: 17711906 Review.
-
Rationale and strategies for reevaluating the ACR20.J Rheumatol. 2007 May;34(5):1184-7. J Rheumatol. 2007. PMID: 17477484
Cited by
-
Topological structural characteristics in patients with systemic lupus erythematosus with and without neuropsychiatric symptoms.Lupus Sci Med. 2024 Sep 11;11(2):e001221. doi: 10.1136/lupus-2024-001221. Lupus Sci Med. 2024. PMID: 39266226 Free PMC article.
-
Application of the 2022 ACR/EULAR criteria to Chinese patients with previously diagnosed eosinophilic granulomatosis with polyangiitis: The concordance rate between the 2022 ACR/EULAR criteria and the 1990 criteria for EGPA in China.Medicine (Baltimore). 2024 Jan 26;103(4):e37119. doi: 10.1097/MD.0000000000037119. Medicine (Baltimore). 2024. PMID: 38277533 Free PMC article.
-
Development of the Takayasu Arteritis Integrated Disease Activity Index.Arthritis Care Res (Hoboken). 2024 Apr;76(4):531-540. doi: 10.1002/acr.25275. Epub 2024 Jan 26. Arthritis Care Res (Hoboken). 2024. PMID: 38059340 Review.
-
Efficacy of Fractional CO2 Laser for Improvement of Limited Mouth Opening in Systemic Sclerosis.J Cutan Aesthet Surg. 2022 Oct-Dec;15(4):387-393. doi: 10.4103/JCAS.JCAS_29_21. J Cutan Aesthet Surg. 2022. PMID: 37035592 Free PMC article.
-
Functional respiratory impairment and related factors in patients with interstitial pneumonia with autoimmune features (IPAF): Multicenter study from NEREA registry.Respir Res. 2023 Jan 18;24(1):19. doi: 10.1186/s12931-023-02317-5. Respir Res. 2023. PMID: 36653833 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
